Opus Genetics, Inc. (Nasdaq: IRD), a clinical-stage biotechnology company developing gene therapies for the treatment of inherited retinal diseases (IRDs) and other treatments for ophthalmic disorders ...

A presentation is planned to update the public on progress of the Smoky Hill River Renewal Project. The City of Salina and ...

The conference will also address the adoption of smart and sustainable city models that focus on multi-resource development ...

Jacksonville gets proposal to build new jail from firms involved in EverBank Field design and Duval County Public Schools ...

More than 65 experts representing government, national labs and industry met to address security challenges for critical infrastructure in current and emerging issues related to artificial ...

NXP900 clinical data presentation from the Phase 1a dose escalation study at the 2025 American Association for Cancer ...

Two Sweet Briar engineering teams took top honors at the prestigious SIEDS 2025 Symposium, highlighting the College’s ...

C4IR Telangana Life Sciences Skilling Program collaboration with TLS, industry, and academia to bridge skilled workforce gap.

Q1 2025 Results Conference Call May 7, 2025 2:30 AM ETCompany ParticipantsKarl Hersvik - Chief Executive OfficerDavid Tønne ...

KCFD’s dated facilities, some of which are approaching 100 years old, are largely in what union and department representatives called “poor” and “deplorable” conditions.

Phase 1 dosing completed for NBD1 stabilizers SION-719 & SION-451; both compounds continue to be generally well tolerated Phase 1 topline data anticipated this quarter On track to initiate Phase 2a pr ...